Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Bisoprolol fumarate
Milpharm Ltd
C07AB07
Bisoprolol fumarate
10mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02040000; GTIN: 8901175013418
PACKAGE LEAFLET: INFORMATION FOR THE USER BISOPROLOL FUMARATE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again If you have any further questions, ask your doctor or pharmacist This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If any of the side effects talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Bisoprolol is and what it is used for 2. What you need to know before you take Bisoprolol 3. How to take Bisoprolol 4. Possible side effects. 5. How to store Bisoprolol 6. Contents of the pack and other information The name of this medicine is Bisoprolol 5mg Tablets or Bisoprolol 10mg Tablets referred to as Bisoprolol throughout this leaflet. Bisoprolol belongs to a group of medicines commonly called ‘beta-blockers’ which work by blocking the transmission of certain nerve impulses. Bisoprolol is used to help treat: angina pectoris (chest pain) hypertension (high blood pressure). DO NOT TAKE BISOPROLOL IF YOU: are allergic (hypersensitive) to bisoprolol or any of the other ingredients in this medicine (listed in Section 6) are in acute heart failure or if you require injection of inotropic drugs (drugs which increase the force of contraction of the heart) have had cardiogenic shock (a condition in which your heart is unable to pump enough blood to your body) suffer from heart block suffer from low heart rate or your heart rate is abnormal because of a condition known as sick sinus syndrome have very poor circulation or Raynaud’s Syndrome have unusually low blood pressure have a tumour of the adrenal gland (phaeochromocytoma) suffer from severe asthma or have severe breathing difficulties suffer from metabolic acidosis (a d Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Bisoprolol Fumarate 10mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10mg of the active ingredient bisoprolol fumarate. For excipients, see 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet White, round tablets engraved with ‘Bisoprolol 10’ on one side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of hypertension. Treatment of angina pectoris. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Adults:_ The usual dose is 10mg once daily with a maximum recommended dose of 20mg per day. In some patients 5mg per day may be adequate. In patients with final stage impairment of renal function (creatinine clearance <20ml/min) or liver function, the dose should not exceed 10mg bisoprolol once daily. Experience of the use of bisoprolol in renal dialysis patients is limited, however, there is no evidence that the dosage regimen needs to be altered. _Elderly: _ No dosage adjustment is normally required but 5mg per day may be adequate in some patients; as for other adults, dosage may have to be reduced in cases of severe renal or hepatic dysfunction. _ _ _Children: _ There is no paediatric experience with bisoprolol, therefore its use cannot be recommended for children. _Method of administration:_ For oral administration. 4.3 CONTRAINDICATIONS Patients with: • uncontrolled cardiac failure. • cardiogenic shock. • sinoatrial block. • second or third degree AV block. • marked bradycardia (heart rate less than 50 beats/min). • extreme hypotension. • Sick sinus syndrome • Prinzmetal’s (variant) angina. • severe peripheral vascular disease (Raynaud’s disease or syndrome, intermittent claudication). • use of anaesthetics which depress the myocardial activity (e.g. cyclopropane and trichlorethylene). • untreated phaeochromocytoma. • a history of bronchospasm, bronchial asthma or chronic obstructive airways disease. • metabolic acidosis (eg in some diabetics). • after prolonged fasting. • hypersensit Read the complete document